Ciardiello, D.; Martini, G.; Famiglietti, V.; Napolitano, S.; De Falco, V.; Troiani, T.; Latiano, T.P.; Ros, J.; Elez Fernandez, E.; Vitiello, P.P.;
et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941.
https://doi.org/10.3390/cancers13081941
AMA Style
Ciardiello D, Martini G, Famiglietti V, Napolitano S, De Falco V, Troiani T, Latiano TP, Ros J, Elez Fernandez E, Vitiello PP,
et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers. 2021; 13(8):1941.
https://doi.org/10.3390/cancers13081941
Chicago/Turabian Style
Ciardiello, Davide, Giulia Martini, Vincenzo Famiglietti, Stefania Napolitano, Vincenzo De Falco, Teresa Troiani, Tiziana Pia Latiano, Javier Ros, Elena Elez Fernandez, Pietro Paolo Vitiello,
and et al. 2021. "Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer" Cancers 13, no. 8: 1941.
https://doi.org/10.3390/cancers13081941
APA Style
Ciardiello, D., Martini, G., Famiglietti, V., Napolitano, S., De Falco, V., Troiani, T., Latiano, T. P., Ros, J., Elez Fernandez, E., Vitiello, P. P., Maiello, E., Ciardiello, F., & Martinelli, E.
(2021). Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers, 13(8), 1941.
https://doi.org/10.3390/cancers13081941